Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-Small-Cell Lung Adenocarcinoma”

973 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 973 results

Large-scale testing (Phase 3)WithdrawnNCT00055887
What this trial is testing

Chemotherapy and Radiation Therapy With or Without Efaproxiral in Treating Patients With Stage III Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Spectrum Pharmaceuticals, Inc
Early research (Phase 1)Study completedNCT02206334
What this trial is testing

Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Breast Cancer, Non-small Cell Lung Cancer, or Prostate Cancer

Who this might be right for
Male Breast CarcinomaProstate AdenocarcinomaRecurrent Breast Carcinoma+5 more
NRG Oncology 42
Early research (Phase 1)Looking for participantsNCT07166601
What this trial is testing

M0324 as Monotherapy and in Combination With Pembrolizumab or Chemotherapy in Participants With Selected Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
EMD Serono Research & Development Institute, Inc. 77
Early research (Phase 1)Study completedNCT02219711
What this trial is testing

Phase 1/1b Study of MGCD516 in Patients With Advanced Cancer

Who this might be right for
Advanced Cancer
Mirati Therapeutics Inc. 193
Early research (Phase 1)Looking for participantsNCT06447662
What this trial is testing

Learn About the Study Medicine PF-07934040 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Genetic Mutation.

Who this might be right for
Carcinoma, Pancreatic DuctalColorectal NeoplasmsCarcinoma, Non-Small-Cell Lung
Pfizer 330
Testing effectiveness (Phase 2)Looking for participantsNCT07070518
What this trial is testing

Study of GV20-0251 in Participants With Solid Tumor Malignancies

Who this might be right for
Solid Tumor CancerAdult Refractory CancerEndometrial Carcinoma (EC)+6 more
GV20 Therapeutics 350
Testing effectiveness (Phase 2)Ended earlyNCT00958321
What this trial is testing

Positron Emission Tomography and Computed Tomography in Planning Treatment for Patients Undergoing 3-Dimensional Conformal Radiation Therapy for Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery. ICORG 06-35

Who this might be right for
Lung CancerMetastatic Cancer
Cancer Trials Ireland 40
Large-scale testing (Phase 3)Ended earlyNCT01798485
What this trial is testing

Ganetespib in Combination With Docetaxel Versus Docetaxel Alone in Patients With Advanced NSCLC

Who this might be right for
Non-Small-Cell Lung AdenocarcinomaNon-small Cell Lung Cancer Stage IIIBNon-small Cell Lung Cancer Stage IV+1 more
Synta Pharmaceuticals Corp. 696
Early research (Phase 1)Looking for participantsNCT07458347
What this trial is testing

Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation

Who this might be right for
KRAS-mutant Non-small Cell Lung Cancer (NSCLC)KRAS-mutant Pancreatic Ductal Adenocarcinoma (PDAC)KRAS-mutant Colorectal Cancer (CRC)+1 more
Kestrel Therapeutics, Inc. 145
Not applicableStudy completedNCT00310115
What this trial is testing

Motivational Counseling in Preventing Smoking Relapse After Pregnancy in Pregnant Women Who Quit Smoking During Pregnancy

Who this might be right for
Bladder CancerCervical CancerEsophageal Cancer+8 more
M.D. Anderson Cancer Center 469
Testing effectiveness (Phase 2)Active Not RecruitingNCT02664935
What this trial is testing

National Lung Matrix Trial: Multi-drug Phase II Trial in Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung CancerCarcinoma, Squamous CellAdenocarcinoma
University of Birmingham 423
Large-scale testing (Phase 3)Study completedNCT00049543
What this trial is testing

Gefitinib in Treating Patients With Stage IB, II, or IIIA Non-small Cell Lung Cancer That Was Completely Removed by Surgery

Who this might be right for
Adenocarcinoma of the LungAdenosquamous Cell Lung CancerBronchoalveolar Cell Lung Cancer+6 more
National Cancer Institute (NCI) 503
Testing effectiveness (Phase 2)Study completedNCT00365547
What this trial is testing

Topotecan and Bevacizumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Did Not Respond to Previous Systemic Chemotherapy

Who this might be right for
Lung Cancer
Masonic Cancer Center, University of Minnesota 46
Not applicableStudy completedNCT00897793
What this trial is testing

Growth Factor Levels in the Blood of Patients Undergoing Radiation Therapy for Epithelial Cancer

Who this might be right for
Breast CancerColorectal CancerHead and Neck Cancer+2 more
Vanderbilt-Ingram Cancer Center 25
Not applicableStudy completedNCT04740047
What this trial is testing

Cios Mobile 3D Spin for Robotic Bronchoscopy

Who this might be right for
Pulmonary Nodule, SolitaryPulmonary CancerLung Cancer+2 more
Mayo Clinic 38
Large-scale testing (Phase 3)Study completedNCT00966914
What this trial is testing

Phase 3 Study of Tavocept Versus Placebo in Patients With Newly Diagnosed or Relapsed Advanced Primary Adenocarcinoma of the Lung Treated With Docetaxel or Paclitaxel Plus Cisplatin

Who this might be right for
Non-small Cell Lung Cancer
BioNumerik Pharmaceuticals, Inc. 540
Not applicableStudy completedNCT03794128
What this trial is testing

Personalized Neoantigen Cancer Vaccines

Who this might be right for
Non Small Cell Lung CancerColorectal CancerGastroesophageal Adenocarcinoma+2 more
Gritstone bio, Inc. 93
Testing effectiveness (Phase 2)UnknownNCT05675605
What this trial is testing

TY-1091 in Patients With Advanced Solid Tumors

Who this might be right for
RET-altered Non Small Cell Lung CancerMedullary Thyroid CancerRET-altered Papillary Thyroid Cancer+1 more
TYK Medicines, Inc 248
Testing effectiveness (Phase 2)Study completedNCT00368992
What this trial is testing

S0536: Cetuximab, Paclitaxel, Carboplatin, and Bevacizumab in Treating Patients With Advanced Non-Small Cell Lung Cancer

Who this might be right for
Adenocarcinoma of the LungAdenosquamous Cell Lung CancerBronchoalveolar Cell Lung Cancer+5 more
National Cancer Institute (NCI) 110
Testing effectiveness (Phase 2)Looking for participantsNCT05208944
What this trial is testing

THIO Sequenced With Cemiplimab in Advanced NSCLC

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Maia Biotechnology 227
Load More Results